Trivarx Ltd (TRI) - Total Assets
Based on the latest financial reports, Trivarx Ltd (TRI) holds total assets worth AU$24.33 Million AUD (≈ $17.21 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Trivarx Ltd (TRI) shareholders funds for net asset value and shareholders' equity analysis.
Trivarx Ltd - Total Assets Trend (2001–2025)
This chart illustrates how Trivarx Ltd's total assets have evolved over time, based on quarterly financial data.
Trivarx Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Trivarx Ltd's total assets of AU$24.33 Million consist of 9.6% current assets and 90.4% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 9.3% |
| Accounts Receivable | AU$0.00 | 0.0% |
| Inventory | AU$0.00 | 0.0% |
| Property, Plant & Equipment | AU$164.26K | 1.2% |
| Intangible Assets | AU$12.01 Million | 89.1% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2001–2025)
This chart illustrates how Trivarx Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see TRI market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Trivarx Ltd's current assets represent 9.6% of total assets in 2025, a decrease from 26.5% in 2001.
- Cash Position: Cash and equivalents constituted 9.3% of total assets in 2025, down from 23.5% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 89.0% of total assets, an increase from 70.0% in 2001.
- Asset Diversification: The largest asset category is intangible assets at 89.1% of total assets.
Trivarx Ltd Competitors by Total Assets
Key competitors of Trivarx Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Alcidion Group Ltd
AU:ALC
|
Australia | AU$115.63 Million |
|
DocCheck AG
XETRA:AJ91
|
Germany | €53.98 Million |
|
TRELLUS HEALTH LS -0006
F:85Q
|
Germany | €9.22 Million |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$533.91 Million |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$17.99 Million |
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$23.68 Million |
|
Cogstate Ltd
AU:CGS
|
Australia | AU$64.77 Million |
|
Oneview Healthcare Plc
AU:ONE
|
Australia | AU$15.49 Million |
Trivarx Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.45 | 1.11 | 0.75 |
| Quick Ratio | 5.45 | 1.11 | 0.75 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | AU$2.85 Million | AU$86.67K | AU$-306.97K |
Trivarx Ltd - Advanced Valuation Insights
This section examines the relationship between Trivarx Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.88 |
| Latest Market Cap to Assets Ratio | 1.27 |
| Asset Growth Rate (YoY) | 24.7% |
| Total Assets | AU$13.48 Million |
| Market Capitalization | $17.14 Million USD |
Valuation Analysis
Above Book Valuation: The market values Trivarx Ltd's assets above their book value (1.27x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Trivarx Ltd's assets grew by 24.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Trivarx Ltd (2001–2025)
The table below shows the annual total assets of Trivarx Ltd from 2001 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$13.48 Million ≈ $9.54 Million |
+24.75% |
| 2024-06-30 | AU$10.81 Million ≈ $7.65 Million |
+37.00% |
| 2023-06-30 | AU$7.89 Million ≈ $5.58 Million |
-7.05% |
| 2022-06-30 | AU$8.49 Million ≈ $6.01 Million |
-51.16% |
| 2021-06-30 | AU$17.38 Million ≈ $12.30 Million |
+24.02% |
| 2020-06-30 | AU$14.01 Million ≈ $9.92 Million |
+5.34% |
| 2019-06-30 | AU$13.30 Million ≈ $9.41 Million |
-30.22% |
| 2018-06-30 | AU$19.06 Million ≈ $13.49 Million |
-0.97% |
| 2017-06-30 | AU$19.25 Million ≈ $13.62 Million |
+7.42% |
| 2016-06-30 | AU$17.92 Million ≈ $12.68 Million |
+18.02% |
| 2015-06-30 | AU$15.18 Million ≈ $10.74 Million |
+201.13% |
| 2014-06-30 | AU$5.04 Million ≈ $3.57 Million |
-6.95% |
| 2013-06-30 | AU$5.42 Million ≈ $3.83 Million |
-1.05% |
| 2012-06-30 | AU$5.48 Million ≈ $3.87 Million |
+67.12% |
| 2011-06-30 | AU$3.28 Million ≈ $2.32 Million |
+132.63% |
| 2010-06-30 | AU$1.41 Million ≈ $996.65K |
-48.28% |
| 2009-06-30 | AU$2.72 Million ≈ $1.93 Million |
-55.88% |
| 2008-06-30 | AU$6.17 Million ≈ $4.37 Million |
+199.41% |
| 2007-06-30 | AU$2.06 Million ≈ $1.46 Million |
-15.59% |
| 2006-06-30 | AU$2.44 Million ≈ $1.73 Million |
-47.77% |
| 2005-06-30 | AU$4.68 Million ≈ $3.31 Million |
-8.93% |
| 2004-06-30 | AU$5.13 Million ≈ $3.63 Million |
-5.58% |
| 2003-06-30 | AU$5.44 Million ≈ $3.85 Million |
-21.91% |
| 2002-06-30 | AU$6.96 Million ≈ $4.93 Million |
-0.51% |
| 2001-06-30 | AU$7.00 Million ≈ $4.95 Million |
-- |
About Trivarx Ltd
TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Med… Read more